![]() |
|
Names | |
---|---|
IUPAC name
(3R,5R,8R,9S,10S,13S,14S,17R)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol
|
|
Other names
5β-Pregnane-3α,17α,20α-triol
|
|
Identifiers | |
1098-45-9 ![]() |
|
3D model (Jmol) | Interactive image |
ChemSpider |
92121 ![]() |
ECHA InfoCard | 100.012.862 |
PubChem | 101967 |
|
|
|
|
Properties | |
C21H36O3 | |
Molar mass | 336.52 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
Pregnanetriol, or 5β-pregnane-3α,17α,20α-triol is a steroid and inactive metabolite of progesterone.
Urine excretion of pregnanetriol can be measured over a period of 24 hours. Elevated urine pregnanetriol levels suggest adrenogenital syndrome. In monitoring treatment with cortisol replacement, elevated urine pregnanetriol levels indicate insufficient dosage of cortisol.
For females:
For males: